Project Grant R01DA065479
Award Date 6/15/26
Completion Date 3/31/31
Dollars Obligated $644K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10027, USA
Similar Awards
- Federal Grant Award Summary New York University School of Medicine received a $256,165 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on May 15, 2026, with an ultimate completion date of April 30, 2029. The award funds PREP-RISE, a multi-level photovoice intervention designed to improve Pre-Exposure Prophylaxis (PrEP) uptake and adherence among women who inject drugs (WWID). The research addresses critically...
- Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $1.32 million Project Grant to the University of Texas Southwestern Medical Center on August 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the RESTORE (Recovery and Engagement for Stimulant Users on Re-entry) study. The award funds research assessing an integrated intervention combining the FDA-approved DynamiCare mobile application—which delivers contingency management (CM)...
- Federal Grant Award Summary The University of Miami received a $677,248 Project Grant awarded February 15, 2026, through the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). This randomized controlled trial will develop and test the Comprehensive Telehealth Concierge (C-THR) Model, a peer-driven, telehealth-based intervention designed to improve HIV prevention through Pre-Exposure Prophylaxis (PrEP) initiation and retention among...
- Federal Grant Award Summary The University of Connecticut received a $755,118 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded on May 15, 2026, with completion targeted for February 28, 2031. This award supports a multilevel mixed-methods longitudinal study designed to identify and address behavioral and sociocultural drivers of premature Pre-Exposure Prophylaxis (PrEP) discontinuation among men aged 18-35,...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $11.67 million Project Grant to the University of California, San Francisco on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). The five-year award, extending through May 31, 2030, supports an innovative research initiative examining the pathophysiological mechanisms by which methamphetamine (MA) use impacts HIV persistence, immune dysfunction, and organ damage in people with HIV...
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $756,000 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a pilot study on improving Pre-Exposure Prophylaxis (PrEP) engagement among hospitalized people who use substances. The grant, awarded March 15, 2026, with a completion date of February 28, 2029, supports formative research and implementation science activities designed to...
- Federal Project Grant Summary The National Institute on Drug Abuse awarded a $588,669 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) to Public Health Foundation Enterprises, Inc. (doing business as Heluna Health) on April 15, 2026, with completion anticipated by January 31, 2031. The award funds the Street Prep intervention study, which delivers HIV pre-exposure prophylaxis (PrEP) prevention services directly to people who use drugs and individuals experiencing...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Miami $109,652 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct implementation research examining telehealth service delivery models for people who inject drugs (PWID) with concurrent HIV and substance use disorder (SUD). The one-year project, which commenced August 19, 2026, will deliver research outputs analyzing existing healthcare service patterns at organizations...
- Federal Project Grant Summary Columbia University received a $491,655 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025 through June 30, 2028. The grant funds a citizen science intervention study designed to increase HIV, sexually transmitted infection (STI), and hepatitis C virus (HCV) testing uptake and overdose prevention kit utilization among survivors of sex trafficking in New York...
- Federal Grant Award Summary Addinex Technologies, Inc. received a $613,056 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop an enhanced medication adherence and monitoring system for decentralized clinical trials in substance use disorder (SUD) treatment. The award, effective September 1, 2025 through August 31, 2026, funds the adaptation of Addinex's existing medication management platform to enable...